1. Home
  2. IVZ vs BCPC Comparison

IVZ vs BCPC Comparison

Compare IVZ & BCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVZ
  • BCPC
  • Stock Information
  • Founded
  • IVZ 1935
  • BCPC 1967
  • Country
  • IVZ United States
  • BCPC United States
  • Employees
  • IVZ N/A
  • BCPC N/A
  • Industry
  • IVZ Investment Managers
  • BCPC Major Chemicals
  • Sector
  • IVZ Finance
  • BCPC Industrials
  • Exchange
  • IVZ Nasdaq
  • BCPC Nasdaq
  • Market Cap
  • IVZ 6.4B
  • BCPC 5.3B
  • IPO Year
  • IVZ 1995
  • BCPC N/A
  • Fundamental
  • Price
  • IVZ $16.31
  • BCPC $162.70
  • Analyst Decision
  • IVZ Hold
  • BCPC Strong Buy
  • Analyst Count
  • IVZ 15
  • BCPC 1
  • Target Price
  • IVZ $17.42
  • BCPC $180.00
  • AVG Volume (30 Days)
  • IVZ 4.9M
  • BCPC 164.0K
  • Earning Date
  • IVZ 07-22-2025
  • BCPC 07-25-2025
  • Dividend Yield
  • IVZ 5.32%
  • BCPC 0.55%
  • EPS Growth
  • IVZ N/A
  • BCPC 17.80
  • EPS
  • IVZ 1.24
  • BCPC 4.17
  • Revenue
  • IVZ $6,120,900,000.00
  • BCPC $964,544,000.00
  • Revenue This Year
  • IVZ N/A
  • BCPC $8.63
  • Revenue Next Year
  • IVZ $3.34
  • BCPC $6.85
  • P/E Ratio
  • IVZ $12.71
  • BCPC $37.98
  • Revenue Growth
  • IVZ 6.02
  • BCPC 3.76
  • 52 Week Low
  • IVZ $11.60
  • BCPC $145.70
  • 52 Week High
  • IVZ $19.55
  • BCPC $186.03
  • Technical
  • Relative Strength Index (RSI)
  • IVZ 66.06
  • BCPC 43.24
  • Support Level
  • IVZ $14.51
  • BCPC $157.19
  • Resistance Level
  • IVZ $15.83
  • BCPC $160.79
  • Average True Range (ATR)
  • IVZ 0.31
  • BCPC 3.18
  • MACD
  • IVZ 0.11
  • BCPC -0.26
  • Stochastic Oscillator
  • IVZ 97.83
  • BCPC 44.18

About IVZ Invesco Ltd

Invesco provides investment-management services to retail (67% of managed assets) and institutional (33%) clients. At the end of April 2025, the firm had $1.840 trillion in assets under management spread among its equity (57% of AUM), balanced (3%), fixed-income (22%), alternative investment (7%), and money market (11%) operations. Passive products account for 43% of Invesco's total AUM, including 65% of the company's equity operations and 15% of its fixed-income platform. Invesco's US retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside of North America, with 30% of its AUM sourced from Europe, Africa, and the Middle East (15%) and Asia (15%).

About BCPC Balchem Corporation

Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.

Share on Social Networks: